Understanding what autoimmune diseases are, what triggers them and how they’re treated can be a powerful first step toward ...

Asal Shirazi, Founder of ASA Foundation, shares insights into what drives inflammatory responses, including the role of ...

The deal marks Lilly’s first in the M&A arena in 2026 as the company diversifies its pipeline beyond obesity drugs.

Under normal conditions, cytokines aid in pathogen recognition and elimination while contributing to immune system ...

Sanofi has returned to U.S. artificial intelligence research biotech Earendil Labs for another significant autoimmune and ...

SaveHealth reports on common rheumatoid arthritis medications, highlighting their effectiveness, side effects, and cost ...

When inflammation in the body goes unchecked, it can cause fibrosis, or tissue scarring that may lead to organ dysfunction or ...

Eli Lilly and Company and Ventyx Biosciences entered into a definitive agreement under which Eli Lilly will acquire Ventyx in ...

FDA Clears IND Allowing Phase 2a Trial of NAV-240 in Hidradenitis Suppurativa to Begin Dosing in Q1 2026HREC Approval ...

In a conversation with Dr. Steven Gundry, I reflect on what the gut–brain connection reveals about inflammation, longevity, ...

Taking anti-inflammatory drugs after surgery is fairly standard protocol. But a new study from researchers at Michigan State ...